Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 268

1.

Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.

Meka VG, Pillai SK, Sakoulas G, Wennersten C, Venkataraman L, DeGirolami PC, Eliopoulos GM, Moellering RC Jr, Gold HS.

J Infect Dis. 2004 Jul 15;190(2):311-7. Epub 2004 Jun 9.

PMID:
15216466
2.

Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.

Pillai SK, Sakoulas G, Wennersten C, Eliopoulos GM, Moellering RC Jr, Ferraro MJ, Gold HS.

J Infect Dis. 2002 Dec 1;186(11):1603-7. Epub 2002 Nov 4.

PMID:
12447736
3.

Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus.

Tsakris A, Pillai SK, Gold HS, Thauvin-Eliopoulos C, Venkataraman L, Wennersten C, Moellering RC Jr, Eliopoulos GM.

J Antimicrob Chemother. 2007 Sep;60(3):649-51. Epub 2007 Jul 10.

PMID:
17623697
4.

Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus.

Meka VG, Gold HS, Cooke A, Venkataraman L, Eliopoulos GM, Moellering RC Jr, Jenkins SG.

J Antimicrob Chemother. 2004 Oct;54(4):818-20. Epub 2004 Sep 3.

PMID:
15347637
5.

Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus.

Morales G, Picazo JJ, Baos E, Candel FJ, Arribi A, Peláez B, Andrade R, de la Torre MA, Fereres J, Sánchez-García M.

Clin Infect Dis. 2010 Mar 15;50(6):821-5. doi: 10.1086/650574.

PMID:
20144045
6.

Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances.

Besier S, Ludwig A, Zander J, Brade V, Wichelhaus TA.

Antimicrob Agents Chemother. 2008 Apr;52(4):1570-2. doi: 10.1128/AAC.01098-07. Epub 2008 Jan 22.

7.

Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis.

Gales AC, Sader HS, Andrade SS, Lutz L, Machado A, Barth AL.

Int J Antimicrob Agents. 2006 Apr;27(4):300-2. Epub 2006 Mar 9.

PMID:
16527459
8.

Resistance to linezolid in a methicillin-susceptible Staphylococcus aureus clinical isolate without previous exposure to oxazolidinones.

Quiles-Melero I, García-Perea A, de Pablos M, Gómez-Gil R, Mingorance J.

Int J Med Microbiol. 2012 Jul;302(3):145-7. doi: 10.1016/j.ijmm.2012.03.001. Epub 2012 May 9.

PMID:
22578666
9.

Sequential linezolid-resistant Staphylococcus epidermidis isolates with G2576T mutation.

Hong T, Li X, Wang J, Sloan C, Cicogna C.

J Clin Microbiol. 2007 Oct;45(10):3277-80. Epub 2007 Aug 1.

10.

Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan.

Ikeda-Dantsuji Y, Hanaki H, Sakai F, Tomono K, Takesue Y, Honda J, Nonomiya Y, Suwabe A, Nagura O, Yanagihara K, Mikamo H, Fukuchi K, Kaku M, Kohno S, Yanagisawa C, Nakae T, Yoshida K, Niki Y.

J Infect Chemother. 2011 Feb;17(1):45-51. doi: 10.1007/s10156-010-0085-1. Epub 2010 Jul 7.

PMID:
20607345
11.

Linezolid resistance in Staphylococcus epidermidis associated with a G2603T mutation in the 23S rRNA gene.

Lincopan N, de Almeida LM, Elmor de Araújo MR, Mamizuka EM.

Int J Antimicrob Agents. 2009 Sep;34(3):281-2. doi: 10.1016/j.ijantimicag.2009.02.023. Epub 2009 Apr 18. No abstract available. Erratum in: Int J Antimicrob Agents. 2012 Feb;39(2):186.

PMID:
19376688
12.

First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States.

Mendes RE, Deshpande LM, Castanheira M, DiPersio J, Saubolle MA, Jones RN.

Antimicrob Agents Chemother. 2008 Jun;52(6):2244-6. doi: 10.1128/AAC.00231-08. Epub 2008 Apr 7.

13.

Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis.

Marshall SH, Donskey CJ, Hutton-Thomas R, Salata RA, Rice LB.

Antimicrob Agents Chemother. 2002 Oct;46(10):3334-6.

14.

Characterisation of Staphylococcus aureus and Enterococcus faecalis mutants with reduced susceptibility to the investigational oxazolidinone RWJ-416457.

Santoro CM, Bush K, Abbanat D.

Int J Antimicrob Agents. 2010 Nov;36(5):424-9. doi: 10.1016/j.ijantimicag.2010.07.007. Epub 2010 Sep 17.

PMID:
20846828
15.

Nosocomial outbreak of methicillin- and linezolid-resistant Staphylococcus epidermidis associated with catheter-related infections in intensive care unit patients.

Seral C, Sáenz Y, Algarate S, Duran E, Luque P, Torres C, Castillo FJ.

Int J Med Microbiol. 2011 Apr;301(4):354-8. doi: 10.1016/j.ijmm.2010.11.001. Epub 2011 Jan 14.

PMID:
21236728
16.

Decreased linezolid uptake in an in vitro-selected linezolid-resistant Staphylococcus epidermidis mutant.

Sierra JM, Ortega M, Tarragó C, Albet C, Vila J, Terencio J, Guglietta A.

J Antimicrob Chemother. 2009 Nov;64(5):990-2. doi: 10.1093/jac/dkp309. Epub 2009 Aug 27.

PMID:
19717395
17.

Use of pyrosequencing to identify point mutations in domain V of 23S rRNA genes of linezolid-resistant Staphylococcus aureus and Staphylococcus epidermidis.

Zhu W, Tenover FC, Limor J, Lonsway D, Prince D, Dunne WM Jr, Patel JB.

Eur J Clin Microbiol Infect Dis. 2007 Mar;26(3):161-5.

PMID:
17393201
18.

Ribosomal and non-ribosomal resistance to oxazolidinones: species-specific idiosyncrasy of ribosomal alterations.

Sander P, Belova L, Kidan YG, Pfister P, Mankin AS, Böttger EC.

Mol Microbiol. 2002 Dec;46(5):1295-304.

19.

Recombination proficiency influences frequency and locus of mutational resistance to linezolid in Enterococcus faecalis.

Lobritz M, Hutton-Thomas R, Marshall S, Rice LB.

Antimicrob Agents Chemother. 2003 Oct;47(10):3318-20.

20.

Molecular characterization of linezolid-resistant CoNS isolates in Japan.

Takaya A, Kimura A, Sato Y, Ishiwada N, Watanabe M, Matsui M, Shibayama K, Yamamoto T.

J Antimicrob Chemother. 2015 Mar;70(3):658-63. doi: 10.1093/jac/dku443. Epub 2014 Nov 6.

PMID:
25381168

Supplemental Content

Support Center